P. Schoenfeld Asset Management (PSAM)’s Verona Pharma VRNA Stock Holding History

P. Schoenfeld Asset Management (PSAM)’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-221,200	Closed	-$23.6M	–	55
2025 Q3	$23.6M	Buy	+221,200	New	+$23.1M	4.42%	9

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

P. Schoenfeld Asset Management (PSAM)'s VRNA Position: Q4 2025 in Review

P. Schoenfeld Asset Management (PSAM) sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 221,200 shares — an estimated $23.6M sold.

P. Schoenfeld Asset Management (PSAM) first reported a position in VRNA in Q3 2025 and held it in 1 quarter. The position peaked at $23.6M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

P. Schoenfeld Asset Management (PSAM) reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
P. Schoenfeld Asset Management (PSAM) sold 221,200 Verona Pharma shares in Q4 2025, an estimated $23.6M.
P. Schoenfeld Asset Management (PSAM) first reported a position in Verona Pharma in Q3 2025 and held it in 1 quarter.
P. Schoenfeld Asset Management (PSAM)'s Verona Pharma position peaked at $23.6M in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on P. Schoenfeld Asset Management (PSAM)'s 13F filing for Q4 2025, filed 13 Feb 2026.